Literature DB >> 9711230

Scavenger receptor family proteins: roles for atherosclerosis, host defence and disorders of the central nervous system.

Y Yamada1, T Doi, T Hamakubo, T Kodama.   

Abstract

In this review, we summarize the structure and function of the scavenger receptor family of proteins including class A (type I and II macrophage scavenger receptors, MARCO), class B (CD36, scavenger receptor class BI), mucinlike (CD68/macrosialin, dSR-CI) and endothelial (LOX-1) receptors. Two motifs have been identified as ligand-binding domains: a charged collagen structure of type I and II receptors, and an immunodominant domain of CD36. These structures can recognize a wide range of negatively charged macromolecules, including oxidized low-density lipoproteins, damaged or apoptotic cells, and pathogenic microorganisms. After binding, these ligands can be either internalized by endocytosis or phagocytosis, or remain at the cell surface and mediate adhesion or lipid transfer through caveolae. Under physiological conditions, scavenger receptors serve to scavenge or clean up cellular debris and other related materials, and they play a role in host defence. In pathological states, they mediate the recruitment, activation and transformation of macrophages and other cells which may be related to the development of atherosclerosis and to disorders caused by the accumulation of denatured materials, such as Alzheimer's disease.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9711230     DOI: 10.1007/s000180050191

Source DB:  PubMed          Journal:  Cell Mol Life Sci        ISSN: 1420-682X            Impact factor:   9.261


  60 in total

1.  Plasmodium yoelii sporozoites infect CD36-deficient mice.

Authors:  Photini Sinnis; Maria Febbraio
Journal:  Exp Parasitol       Date:  2002-01       Impact factor: 2.011

2.  Disease-associated prion protein in vessel walls.

Authors:  Oskar Koperek; Gábor G Kovács; Diane Ritchie; James W Ironside; Herbert Budka; Georg Wick
Journal:  Am J Pathol       Date:  2002-12       Impact factor: 4.307

Review 3.  Inflammation and atherosclerosis.

Authors:  Mehdi H Shishehbor; Deepak L Bhatt
Journal:  Curr Atheroscler Rep       Date:  2004-03       Impact factor: 5.113

Review 4.  Infectious diseases of marine molluscs and host responses as revealed by genomic tools.

Authors:  Ximing Guo; Susan E Ford
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2016-03-05       Impact factor: 6.237

5.  ABCG1 (ABC8), the human homolog of the Drosophila white gene, is a regulator of macrophage cholesterol and phospholipid transport.

Authors:  J Klucken; C Büchler; E Orsó; W E Kaminski; M Porsch-Ozcürümez; G Liebisch; M Kapinsky; W Diederich; W Drobnik; M Dean; R Allikmets; G Schmitz
Journal:  Proc Natl Acad Sci U S A       Date:  2000-01-18       Impact factor: 11.205

6.  Identification and characterization of class B scavenger receptor CD36 from the hard tick, Haemaphysalis longicornis.

Authors:  Kyaw Min Aung; Damdinsuren Boldbaatar; Min Liao; Rika Umemiya-Shirafuji; Sumihiro Nakao; Terushige Matsuoka; Tetsuya Tanaka; Kozo Fujisaki
Journal:  Parasitol Res       Date:  2010-09-25       Impact factor: 2.289

7.  Differential infection of mononuclear phagocytes by Francisella tularensis: role of the macrophage mannose receptor.

Authors:  Grant S Schulert; Lee-Ann H Allen
Journal:  J Leukoc Biol       Date:  2006-06-30       Impact factor: 4.962

Review 8.  Immunological aspects of atherosclerosis.

Authors:  S Garrido-Urbani; M Meguenani; F Montecucco; B A Imhof
Journal:  Semin Immunopathol       Date:  2013-11-09       Impact factor: 9.623

9.  Management of oxidative stress in the CNS: the many roles of glutathione.

Authors:  B H Juurlink
Journal:  Neurotox Res       Date:  1999-12       Impact factor: 3.911

10.  C-reactive protein binds to both oxidized LDL and apoptotic cells through recognition of a common ligand: Phosphorylcholine of oxidized phospholipids.

Authors:  Mi-Kyung Chang; Christoph J Binder; Michael Torzewski; Joseph L Witztum
Journal:  Proc Natl Acad Sci U S A       Date:  2002-09-20       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.